What antibiotic regimens are appropriate for a 14-year-old girl weighing 52 kg with a lower urinary tract infection or an upper urinary tract infection (pyelonephritis)?

Antibiotic Options for 14-Year-Old Girl with UTI

For lower urinary tract infection (cystitis), treat with nitrofurantoin 100 mg twice daily for 5 days or trimethoprim-sulfamethoxazole 160/800 mg (one double-strength tablet) twice daily for 3 days if local resistance is <20%. 1

For upper urinary tract infection (pyelonephritis), treat with oral ciprofloxacin 500 mg twice daily for 7 days if local fluoroquinolone resistance is <10%, or levofloxacin 750 mg once daily for 5 days. 1, 2

Lower Urinary Tract Infection (Cystitis)

First-Line Options

• Nitrofurantoin: 100 mg twice daily for 5 days 1, 3

  • Preferred choice due to minimal resistance and collateral damage
  • Highly effective with resistance rates as low as 0.5% in pediatric populations 4

• Trimethoprim-sulfamethoxazole (TMP-SMX): 160/800 mg twice daily for 3 days 1

  • Only if local E. coli resistance <20%
  • Critical caveat: Pediatric resistance rates to TMP-SMX can reach 24-27%, making this less reliable empirically 4

Alternative Options (when first-line cannot be used)

• Pivmecillinam: 400 mg twice daily for 3-7 days 1

  • Excellent choice where available (limited to some European countries)
  • Resistance rate only 4% in pediatric populations 4

• Beta-lactams (use with caution): 1

  • Amoxicillin-clavulanate: 3-7 days
  • Cefdinir, cefaclor, cefpodoxime: 3-7 days
  • Cephalexin: 3-7 days (less studied but acceptable)
  • Important limitation: Generally inferior efficacy compared to other agents

• Fluoroquinolones: Reserve for situations where other agents cannot be used 1

  • Ciprofloxacin or levofloxacin: 3 days
  • Should be avoided for simple cystitis due to collateral damage concerns

Agents to AVOID

• Amoxicillin or ampicillin alone: Do not use empirically due to high resistance rates worldwide 1
• Fosfomycin: While acceptable (3g single dose), has inferior efficacy compared to standard regimens 1

Upper Urinary Tract Infection (Pyelonephritis)

Critical First Step

Always obtain urine culture and susceptibility testing before initiating therapy 1

Outpatient Treatment (Not Requiring Hospitalization)

First-Line Fluoroquinolones (if local resistance <10%): 1

• Ciprofloxacin: 500 mg twice daily for 7 days
• Levofloxacin: 750 mg once daily for 5 days 1, 2

If fluoroquinolone resistance >10%: Give initial IV dose of long-acting parenteral agent, then continue oral therapy 1

• Ceftriaxone 1g IV once, followed by oral agent
• OR consolidated 24-hour aminoglycoside dose, followed by oral agent

Alternative Oral Agents

• TMP-SMX: 160/800 mg twice daily for 14 days 1

  • Only if organism known to be susceptible
  • If used empirically, must give initial IV ceftriaxone 1g or aminoglycoside dose

• Oral cephalosporins: 2, 3

  • Cefpodoxime: 200 mg twice daily for 10 days
  • Ceftibuten: 400 mg once daily for 10 days
  • Must give initial IV ceftriaxone 1g if used empirically 1
  • Less effective than fluoroquinolones or TMP-SMX

Hospitalized Patients (Severe Illness)

Initial IV therapy with: 1

• Fluoroquinolone: Ciprofloxacin 400 mg IV twice daily OR levofloxacin 750 mg IV daily
• Ceftriaxone: 1-2g IV daily 2
• Cefepime: 1-2g IV twice daily 2
• Aminoglycoside ± ampicillin: Gentamicin 5 mg/kg IV daily or amikacin 15 mg/kg IV daily 2
• Piperacillin-tazobactam: 2.5-4.5g IV three times daily 2

Tailor therapy based on culture results and local resistance patterns 1

Key Clinical Considerations

Resistance Thresholds Matter

The 20% resistance threshold for cystitis and 10% threshold for pyelonephritis are evidence-based cutoffs that should guide empirical selection 1. Know your local antibiogram.

Duration Optimization

Recent evidence supports shorter courses: 3, 5, 6

• Cystitis: 3-5 days is adequate for uncomplicated cases
• Pyelonephritis: 5-7 days with fluoroquinolones, 7 days with beta-lactams
• Avoid unnecessarily prolonged courses (10-14 days) unless specifically indicated

Common Pitfalls

1. Using third-generation cephalosporins unnecessarily: Studies show 51% of pediatric UTI encounters receive ceftriaxone, with 80% receiving it unnecessarily 7

2. Treating asymptomatic bacteriuria: 40% of mixed flora/nonuropathogen cultures still receive antibiotics inappropriately 7

3. Assuming all dysuria is cystitis: 22.8% of pyelonephritis patients present without flank pain or CVA tenderness 8. Consider imaging if high-risk features present.

4. Ignoring local resistance patterns: E. coli resistance to TMP-SMX reaches 24-27% in some pediatric populations, making empirical use problematic 4

Adolescent-Specific Considerations

At 14 years old and 52 kg, this patient can receive adult dosing for most agents 9. However, consider that adolescent UTIs are markers for sexual activity—screen for sexually transmitted infections and provide appropriate counseling 9.

When to Escalate

If patient remains febrile after 72 hours of appropriate therapy, obtain imaging to evaluate for complications such as obstruction or abscess 2. Switch to broader-spectrum agents only if culture demonstrates resistant organism or clinical deterioration occurs.